
Stanford, CA
Affiliated with a Castle Connolly Top Hospital
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
For detailed information, please contact Dr. Berube's office.
All Other Third Party
Blue Shield of California
Central California Alliance for Health
CVS Health (formerly Aetna)
Express Scripts
Medicaid
Medicare
Santa Clara Family Health Plan
State of California
UnitedHealthcare
View All Insurances
550 Hamilton Ave Ste 208
Palo Alto, CA 94301
(650) 330-1636
Sequential azacitidine plus lelidomide combition
Haematologica, 2013
Accessory splenules in autoimmune hemolytic anemia
AMERICAN JOURL OF HEMATOLOGY, 2013
Safety, efficacy and biological predictors of response to sequential azacitidine and lelidomide for
LEUKEMIA, 2012
Phase I trial of a novel human monoclol antibody mAb216 in patients with relapsed or refractory B
HAEMATOLOGICA-THE HEMATOLOGY JOURL, 2012
Moxifloxacin-acetaminophen
AMERICAN JOURL OF HEALTH-SYSTEM PHARMACY, 2011
Second-line mitoxantrone, etoposide
AMERICAN JOURL OF HEMATOLOGY, 2010
Activity of the tyrosine kise inhibitor PKC412
BLOOD, 2005
Sequential azacitidine plus lenalidomide combination
Haematologica, 2013
Accessory splenules in autoimmune hemolytic anemia
AMERICAN JOURNAL OF HEMATOLOGY, 2013
Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide
LEUKEMIA, 2012
Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012
Moxifloxacin-acetaminophen
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011
Second-line mitoxantrone, etoposide
AMERICAN JOURNAL OF HEMATOLOGY, 2010
Extending and evaluating a warfarin dosing algorithm that includes CYP4F2
PHARMACOGENETICS AND GENOMICS, 2010
Activity of the tyrosine kinase inhibitor PKC412
BLOOD, 2005